It gives Novo Nordisk an opportunity to remain competitive on efficacy while it continues developing next-generation therapies. Other drugs have already shown greater efficacy in prior studies, and the broader GLP-1 space is likely to see much more significant change as new molecules enter the market. Balazs called the higher dosage a major jump, noting that the incidences of stomach- and skin-related side effects at this higher dose are meaningful. CLICK HERE FOR MORE HEALTH STORIES This approval is for obesity management, not diabetes treatment, the expert emphasized
Ofrecemos envos rpidos y atencin al cliente especializada.
Busy professionals, travelers, families and individuals recovering at home often prefer the ability to receive treatment without commuting
But first, a warning: you should not take Wegovy, Ozempic or Mounjaro while pregnant, breastfeeding or trying to conceive
Bo qun Ni kh ro, trnh nh nng trc tip do mt tri chiu vo